Does magnesium sulphate reduce length of stay and improve spirometry in acute moderate to severe asthma when initial treatment fails?

Not Applicable

Completed

• Conditions: asthma; Respiratory - Asthma

• Registration Number: ACTRN12612000838819
• Lead Sponsor: maureen busuttil

Brief Summary

insufficient numbers for meaningful statistical analysis of the effects of magnesium in the study cohort.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-08-09
• Study Completion: 2017-09-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

Acute asthma exacerbation requiring attendance to an emergency department

Exclusion Criteria

life threatening asthma
pregnancy
other respiratory diseases eg pulmonary embolis,pneumonia

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
discharge from hospital[4 hours post intervention ( treatment with magnesium)];total duration of stay in hospital in hours[from time of enrollment to discharge from hospital]

Secondary Outcome Measures

Name	Time	Method
Improvement in lung function as measured by spirometry[4 hours post intervention and at followup 72 hours post intervention];withdrawl from trial[at any time from enrolment to 4 hours post intervention];need for admission to intensive care[from time of enrollment to discharge from hospital];need for invasive or non invasive ventilation[from time of enrollment to discharge from hospital]